HYPERION DEFI, INC. Dilutive Securities, Effect on Basic Earnings Per Share
HYPERION DEFI, INC. (HYPD) reported Dilutive Securities, Effect on Basic Earnings Per Share of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:DilutiveSecurities · last filed 2026-08-13
- HYPERION DEFI, INC. dilutive securities, effect on basic earnings per share for the quarter ending 2025-12-31 was $0.00.
- HYPERION DEFI, INC. dilutive securities, effect on basic earnings per share for the quarter ending 2025-09-30 was $0.00.
- HYPERION DEFI, INC. dilutive securities, effect on basic earnings per share for the quarter ending 2025-06-30 was $0.00.
- HYPERION DEFI, INC. dilutive securities, effect on basic earnings per share for the quarter ending 2025-03-31 was $0.00.
- HYPERION DEFI, INC. dilutive securities, effect on basic earnings per share for fiscal 2025 was $0.00.
- HYPERION DEFI, INC. dilutive securities, effect on basic earnings per share for fiscal 2024 was $0.00.
| Period end | Dilutive Securities, Effect on Basic Earnings Per Share 3 month | Dilutive Securities, Effect on Basic Earnings Per Share 6 month | Dilutive Securities, Effect on Basic Earnings Per Share 9 month | Dilutive Securities, Effect on Basic Earnings Per Share 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $0.00 10-Q · filed 2025-11-14 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | $0.00 derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 10-K · filed 2026-03-30 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-14 | $0.00 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |